[go: up one dir, main page]

IL96995A0 - Pharmaceutical compositions containing pimobendan and their preparation - Google Patents

Pharmaceutical compositions containing pimobendan and their preparation

Info

Publication number
IL96995A0
IL96995A0 IL96995A IL9699591A IL96995A0 IL 96995 A0 IL96995 A0 IL 96995A0 IL 96995 A IL96995 A IL 96995A IL 9699591 A IL9699591 A IL 9699591A IL 96995 A0 IL96995 A0 IL 96995A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
pimobendan
containing pimobendan
Prior art date
Application number
IL96995A
Other versions
IL96995A (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL96995A0 publication Critical patent/IL96995A0/en
Publication of IL96995A publication Critical patent/IL96995A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Pimobendan dosage forms for oral administration contain citric acid, ensuring constantly good absorption even with large pH variations in the gastrointestinal tract.
IL9699591A 1990-01-20 1991-01-22 Pharmaceutical compositions containing pimobendan and their preparation IL96995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4001622A DE4001622A1 (en) 1990-01-20 1990-01-20 ORAL DRUGS OF PIMOBENDAN

Publications (2)

Publication Number Publication Date
IL96995A0 true IL96995A0 (en) 1992-03-29
IL96995A IL96995A (en) 1994-11-11

Family

ID=6398467

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9699591A IL96995A (en) 1990-01-20 1991-01-22 Pharmaceutical compositions containing pimobendan and their preparation

Country Status (18)

Country Link
EP (1) EP0439030B1 (en)
JP (1) JP2608183B2 (en)
KR (1) KR0163056B1 (en)
AT (1) ATE87481T1 (en)
AU (1) AU630536B2 (en)
CA (1) CA2034569C (en)
DE (2) DE4001622A1 (en)
DK (1) DK0439030T3 (en)
ES (1) ES2054379T3 (en)
FI (1) FI96274C (en)
HK (1) HK175796A (en)
HU (1) HU207948B (en)
IE (1) IE64659B1 (en)
IL (1) IL96995A (en)
NO (1) NO176305C (en)
NZ (1) NZ236834A (en)
PT (1) PT96506B (en)
ZA (1) ZA91372B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753904B1 (en) * 1996-10-01 1998-10-30 Gattefosse Ets Sa PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE OF ACTIVE SUBSTANCE, INCLUDING A MATRIX, AND MANUFACTURING PROCESS
DE102004011512B4 (en) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
WO2005123040A1 (en) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. Tablet rapidly disintegrating in mouth
JP4572296B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
JP2006028130A (en) * 2004-07-21 2006-02-02 Toa Eiyo Ltd Pimobendan oral dosage formulation
JP4572293B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
EP1937270A1 (en) * 2005-09-21 2008-07-02 Brystol-Myers Squibb Company Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
JP4572300B2 (en) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
PE20081482A1 (en) * 2006-12-20 2008-12-23 Novartis Ag GELATINE CAPSULES CONTAINING AN ACID
FR2934156B1 (en) 2008-07-23 2010-09-24 Virbac ORAL ADMINISTRATION MEDICAMENT IN SOLID FORM
WO2010055119A2 (en) * 2008-11-17 2010-05-20 Novartis Ag Pharmaceutical composition comprising pimobendan
BRPI0921868A2 (en) 2008-11-25 2015-12-29 Boehringer Ingelheim Vetmed phosphodiesterase type iii (pde iii) inhibitors or ca2 + sensitizing agents for the treatment of hypertrophic cardiomyopathy
NL1037569C2 (en) 2009-12-18 2011-06-21 Eurovet Animal Health B V Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
WO2011081118A1 (en) * 2009-12-29 2011-07-07 興和株式会社 Pharmaceutical composition for oral administration
JPWO2011081117A1 (en) * 2009-12-29 2013-05-09 興和株式会社 Solid pharmaceutical composition for oral administration
ES2924478T3 (en) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulation of pharmaceutical tablets for the veterinary medical sector, method of production and use thereof
HUE054186T2 (en) 2013-07-19 2021-08-30 Boehringer Ingelheim Vetmedica Gmbh Preserved liquid aqueous pharmaceutical composition containing etherified cyclodextrin derivatives
WO2015082389A1 (en) 2013-12-04 2015-06-11 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN106729723A (en) * 2016-11-21 2017-05-31 青岛农业大学 A kind of pharmaceutical composition containing UD-CG115BS.acardi and preparation method thereof
KR20220006776A (en) * 2020-07-09 2022-01-18 주식회사유한양행 Pharmaceutical compositions comprising a diaminopyrimidine derivative or pharmaceutically acceptable salt thereof and processes for preparing the same
EP4633607A1 (en) 2022-12-15 2025-10-22 Boehringer Ingelheim Vetmedica GmbH Solid dispersions comprising amorphous pimobendan and one or more stabilizing polymers
JP7659339B1 (en) 2023-11-21 2025-04-09 東海カプセル株式会社 Oral film formulation containing pimobendan

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES482789A0 (en) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K PROCEDURE FOR THE PREPARATION OF NEW BENZHIMIDAZOLES REPLACED IN POSITION 5 OR 6 WITH A PYRIDAZINONE RING
DE2837161A1 (en) * 1978-08-25 1980-03-06 Thomae Gmbh Dr K 5-Alkyl:pyridazinyl substd. benzimidazole derivs. - useful as cardiovascular agents, antivirals, interferon inducers and ulcer inhibitors
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
JPS60163823A (en) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd Orally administered formulation
ATE71833T1 (en) * 1986-11-03 1992-02-15 Schering Corp LABETALOL DELAYED-RELEASE TABLET.
DE3728244A1 (en) * 1987-08-25 1989-03-09 Thomae Gmbh Dr K NEW (-) - BENZIMIDAZOLE, THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS
EP0306846A3 (en) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Synergistic combination comprising a phosphodiesterase inhibitor and a thromboxane-a2 antagonist, and its use or preparation
DE3805635A1 (en) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K USE OF BENZIMIDAZOLES FOR THE MANUFACTURE OF A MEDICAMENT WITH ANTI-MIXIC EFFECTS ON THE HEART AND ITS COMBINATIONS WITH SS-BLOCKERS OR BRADYCARDICA
JPH01258621A (en) * 1988-04-06 1989-10-16 Fujimoto Seiyaku Kk Dilazep tablet with regulated absorption
JPH023609A (en) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk Long-acting drug preparation containing nicardipine hydrochloride as active component

Also Published As

Publication number Publication date
NO910213D0 (en) 1991-01-18
IE910165A1 (en) 1991-07-31
PT96506A (en) 1991-10-15
FI910263A0 (en) 1991-01-18
JPH04210919A (en) 1992-08-03
KR910014120A (en) 1991-08-31
FI910263L (en) 1991-07-21
DE4001622A1 (en) 1991-07-25
CA2034569C (en) 2002-03-19
NO176305C (en) 1995-03-15
AU6945491A (en) 1991-07-25
IE64659B1 (en) 1995-08-23
IL96995A (en) 1994-11-11
HU910177D0 (en) 1991-08-28
EP0439030B1 (en) 1993-03-31
NZ236834A (en) 1995-10-26
FI96274C (en) 1996-06-10
PT96506B (en) 1998-06-30
EP0439030A3 (en) 1991-10-16
HU207948B (en) 1993-07-28
NO910213L (en) 1991-07-22
HUT56494A (en) 1991-09-30
EP0439030A2 (en) 1991-07-31
AU630536B2 (en) 1992-10-29
HK175796A (en) 1996-09-27
JP2608183B2 (en) 1997-05-07
CA2034569A1 (en) 1991-07-21
ATE87481T1 (en) 1993-04-15
FI96274B (en) 1996-02-29
ZA91372B (en) 1992-09-30
NO176305B (en) 1994-12-05
KR0163056B1 (en) 1998-12-01
DE59100067D1 (en) 1993-05-06
ES2054379T3 (en) 1994-08-01
DK0439030T3 (en) 1993-08-16

Similar Documents

Publication Publication Date Title
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
IL100899A0 (en) Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ITBO910024A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
IL116673A (en) Stable oral pharmaceutical composition containing an acid labile benzimidazole
IL102261A0 (en) 7-isoindolinyl-quinolone-and-naphthyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
DK0667148T3 (en) Oral pharmaceutical composition that is triggered in the lower gastrointestinal tract
AU3113893A (en) Flavour-masked pharmaceutical compositions
IL100677A0 (en) Optically active 5h-pyrrolo(3,4-b)pyrazine derivative,its preparation and pharmaceutical compositions containing it
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CZ49995A3 (en) Pharmaceutical preparation for oral administration
IL103213A (en) Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics
IL103329A0 (en) Imidazole-5-carboxylic acid acylals,their preparation and pharmaceutical compositions containing them
IL103293A0 (en) Substituted imidazolyl-propenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL103292A0 (en) Cyclic-substituted imidazolyl-propenoic acid derivatives,their preparation and pharmaceutical compositions containing them
FI910088L (en) ORAL PHARMACEUTICAL COMPOSITION.
FI934082A7 (en) Chitosan-based nutritional or pharmaceutical compositions for use in ruminants
IL103291A0 (en) Imidazolyl-propenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL98576A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
DE3578597D1 (en) 4-PHENYLPHTHALAZINE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
HUP0101415A3 (en) 3,7-diazabicyclo [3.3.1]-nonane-carboxylic acid salts, pharmaceutical preparation containing thereof, methods for their preparation and their use
ATE145333T1 (en) ORAL DRUGS CONTAINING HIRUDIN
ITRM920535A0 (en) PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION THROUGH THE MUCOSA.
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL97321A0 (en) Diamine derivatives,their manufacture and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired